Adult height and health-related quality of life in patients born small for gestational age treated with recombinant growth hormone
Abstract Health related quality of life (HRQoL) is a relevant result when assessing the course of different pathologies and the efficacy of their treatments. HRQoL has been studied previously on adults born small for gestational age (SGA), both in the general population and in patients who had recei...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2023-02-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-023-30281-z |
| _version_ | 1797865007476637696 |
|---|---|
| author | José Manuel Rial Rodrígez Lourdes Ibañez Toda Ignacio Díez López Jordi Bosch Muñoz Luis Salamanca Fresno Eugenio Fernández Hernández Antonio de Arriba Muñoz |
| author_facet | José Manuel Rial Rodrígez Lourdes Ibañez Toda Ignacio Díez López Jordi Bosch Muñoz Luis Salamanca Fresno Eugenio Fernández Hernández Antonio de Arriba Muñoz |
| author_sort | José Manuel Rial Rodrígez |
| collection | DOAJ |
| description | Abstract Health related quality of life (HRQoL) is a relevant result when assessing the course of different pathologies and the efficacy of their treatments. HRQoL has been studied previously on adults born small for gestational age (SGA), both in the general population and in patients who had received recombinant human growth hormone (rhGH) treatment, with disparate results. Our study included 50 adults who had received rhGH treatment for the SGA indication in 4 Spanish hospitals. Data have been gathered retrospectively from their clinical records, current weight and height were measured, and patients have been asked to fill out SF-36 and QoLAGHDA quality of life forms, and the Graffar test to evaluate their socio-economical status. Patient’s adult height was – 1.2 ± 0.9 SD, lower than their target height of 1 ± 0.8 SD, but gaining 1.7 ± 1 SD from the beginning of the treatment. SF-36 test results showed lower scoring on Mental Health domains than on those related to Physical Health. No correlation was found between HRQoL results and final height, rhGH treatment duration or puberty. Correlation was indeed found between QoLAGHDA and several domains of SF-36, but QoLAGHDA detected fewer patients with low HRQoL than SF-36. Thus, it is concluded that SGA patient’s follow-up should include a HRQoL, neuro-cognitive and psychiatric assessment in their transition to adult age. Adult SGA patients without catch up growth have impaired HRQoL, especially in mental health domains. |
| first_indexed | 2024-04-09T23:01:08Z |
| format | Article |
| id | doaj.art-c7f92c47f9724766b0b18fb47955e2e2 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-04-09T23:01:08Z |
| publishDate | 2023-02-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-c7f92c47f9724766b0b18fb47955e2e22023-03-22T10:59:36ZengNature PortfolioScientific Reports2045-23222023-02-011311710.1038/s41598-023-30281-zAdult height and health-related quality of life in patients born small for gestational age treated with recombinant growth hormoneJosé Manuel Rial Rodrígez0Lourdes Ibañez Toda1Ignacio Díez López2Jordi Bosch Muñoz3Luis Salamanca Fresno4Eugenio Fernández Hernández5Antonio de Arriba Muñoz6Pediatric Endocrinology Unit, Hospiten RamblaPediatric Endocrinology Unit, Hospital Sant Joan de DéuPediatric Endocrinology Unit, Hospital Universitario de ÁlavaPediatric Endocrinology Unit, Arnau de Vilanova HospitalPediatric Endocrinology Unit, La Paz HospitalPediatric Endocrinology Unit, Hispalense Institute of Paediatrics GroupPediatric Endocrinology Unit, Miguel Servet HospitalAbstract Health related quality of life (HRQoL) is a relevant result when assessing the course of different pathologies and the efficacy of their treatments. HRQoL has been studied previously on adults born small for gestational age (SGA), both in the general population and in patients who had received recombinant human growth hormone (rhGH) treatment, with disparate results. Our study included 50 adults who had received rhGH treatment for the SGA indication in 4 Spanish hospitals. Data have been gathered retrospectively from their clinical records, current weight and height were measured, and patients have been asked to fill out SF-36 and QoLAGHDA quality of life forms, and the Graffar test to evaluate their socio-economical status. Patient’s adult height was – 1.2 ± 0.9 SD, lower than their target height of 1 ± 0.8 SD, but gaining 1.7 ± 1 SD from the beginning of the treatment. SF-36 test results showed lower scoring on Mental Health domains than on those related to Physical Health. No correlation was found between HRQoL results and final height, rhGH treatment duration or puberty. Correlation was indeed found between QoLAGHDA and several domains of SF-36, but QoLAGHDA detected fewer patients with low HRQoL than SF-36. Thus, it is concluded that SGA patient’s follow-up should include a HRQoL, neuro-cognitive and psychiatric assessment in their transition to adult age. Adult SGA patients without catch up growth have impaired HRQoL, especially in mental health domains.https://doi.org/10.1038/s41598-023-30281-z |
| spellingShingle | José Manuel Rial Rodrígez Lourdes Ibañez Toda Ignacio Díez López Jordi Bosch Muñoz Luis Salamanca Fresno Eugenio Fernández Hernández Antonio de Arriba Muñoz Adult height and health-related quality of life in patients born small for gestational age treated with recombinant growth hormone Scientific Reports |
| title | Adult height and health-related quality of life in patients born small for gestational age treated with recombinant growth hormone |
| title_full | Adult height and health-related quality of life in patients born small for gestational age treated with recombinant growth hormone |
| title_fullStr | Adult height and health-related quality of life in patients born small for gestational age treated with recombinant growth hormone |
| title_full_unstemmed | Adult height and health-related quality of life in patients born small for gestational age treated with recombinant growth hormone |
| title_short | Adult height and health-related quality of life in patients born small for gestational age treated with recombinant growth hormone |
| title_sort | adult height and health related quality of life in patients born small for gestational age treated with recombinant growth hormone |
| url | https://doi.org/10.1038/s41598-023-30281-z |
| work_keys_str_mv | AT josemanuelrialrodrigez adultheightandhealthrelatedqualityoflifeinpatientsbornsmallforgestationalagetreatedwithrecombinantgrowthhormone AT lourdesibaneztoda adultheightandhealthrelatedqualityoflifeinpatientsbornsmallforgestationalagetreatedwithrecombinantgrowthhormone AT ignaciodiezlopez adultheightandhealthrelatedqualityoflifeinpatientsbornsmallforgestationalagetreatedwithrecombinantgrowthhormone AT jordiboschmunoz adultheightandhealthrelatedqualityoflifeinpatientsbornsmallforgestationalagetreatedwithrecombinantgrowthhormone AT luissalamancafresno adultheightandhealthrelatedqualityoflifeinpatientsbornsmallforgestationalagetreatedwithrecombinantgrowthhormone AT eugeniofernandezhernandez adultheightandhealthrelatedqualityoflifeinpatientsbornsmallforgestationalagetreatedwithrecombinantgrowthhormone AT antoniodearribamunoz adultheightandhealthrelatedqualityoflifeinpatientsbornsmallforgestationalagetreatedwithrecombinantgrowthhormone |